Last updated at 08 Jul 2024 07:48 AM
Director
DIN: 09305547
Krishna Ansiram Yadav is currently associated with 2 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at NASHIK ICU AND TRAUMA CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09305547.Krishna Ansiram Yadav is currently involved in 3 different roles. Their most recent position is with CRANBERRIES PHARMACEUTICALS LLP as a Designated Partner. The first company Krishna Ansiram Yadav was appointed to as a director was NASHIK ICU AND TRAUMA CENTRE PRIVATE LIMITED. Krishna Ansiram Yadav is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Krishna Ansiram Yadav is currently associated with 2 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at NASHIK ICU AND TRAUMA CENTRE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09305547.Krishna Ansiram Yadav is currently involved in 3 different roles. Their most recent position is with CRANBERRIES PHARMACEUTICALS LLP as a Designated Partner. The first company Krishna Ansiram Yadav was appointed to as a director was NASHIK ICU AND TRAUMA CENTRE PRIVATE LIMITED. Krishna Ansiram Yadav is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| NASHIK ICU AND TRAUMA CENTRE PRIVATE LIMITED | Director | 03-Sep-2021 |
| NASHIK ICU AND TRAUMA CENTRE PRIVATE LIMITED | Individual Promoter | 03-Sep-2021 |